FRA:BIO Revenue

In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M EUR with 6.08% growth. Biotest Aktiengesellschaft had revenue of 203.50M in the quarter ending December 31, 2024, with 10.42% growth.

Revenue

726.20M

Revenue Growth

+6.08%

P/S Ratio

1.98

Revenue / Employee

291.06K

Employees

2,495

Market Cap

1.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	726.20M	41.60M	6.08%
Dec 31, 2023	684.60M	168.50M	32.65%
Dec 31, 2022	516.10M	500.00K	0.10%
Dec 31, 2021	515.60M	31.40M	6.48%
Dec 31, 2020	484.20M	65.10M	15.53%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SAP SE	34.18B
Deutsche Telekom AG	118.43B
Siemens Aktiengesellschaft	76.54B
Allianz SE	107.35B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	61.15B
Rheinmetall AG	9.75B
Merck KGaA	21.16B
Siemens Healthineers AG	22.67B

Revenue Rankings

Biotest Aktiengesellschaft News

18 days ago - EQS-WpÜG: Tender Offer / Target company: Biotest AG; Bidder: Grifols Biotest Holdings GmbH - Wallstreet:Online
18 days ago - EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer - Wallstreet:Online
18 days ago - Biotest AG Boosts Sales by 6% in 2024 - Wallstreet:Online
18 days ago - EQS-News: Biotest AG increases sales by 6% in financial year 2024 - Wallstreet:Online
6 weeks ago - EQS-Adhoc: Biotest AG: CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future. - Wallstreet:Online

More News